COPD Clinical Trials

Showing 1381-1400 of 1,722 trials

COMPLETEDPhase 3

Study Evaluating Preference, Satisfaction and Ease of Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD) Diagnosed Patients

NCT01385696

Preference study: Genuair vs HandiHaler inhalers in COPD patients.

Chronic Obstructive Pulmonary Disease (COPD)

Almirall, S.A.130 participantsStarted Jun 2011

Bonn, Germany • Koblenz, Germany • Enschede, Netherlands +1 more locations

UNKNOWN

Long-term Oxygen Treatment (LTOT) in Chronic Obstructive Pulmonary Disease: Factors Influencing Survival

NCT00871962

The purpose of this prospective cohort study is to determine factors involved in survival in new COPD patients treated by long-term oxygen therapy. Background: long-term oxygen therapy is indicated in patients with severe COPD. No studies have been performed in the past 20-25 years to examine the results of early clinical trials. Further studies are necessary to understand the utility of oxygen therapy in severe COPD.

Chronic Obstructive Pulmonary Disease

Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche750 participantsStarted Jun 2009

Limoges, France

COMPLETEDPhase 1

Bioequivalence Study of Synflutide HFA Inhaler and Seretide Evohaler in Healthy Volunteers With Charcoal Block

NCT02466503

The objective of this pivotal study is to evaluate the relative bioavailability of Synflutide HFA 250/25 Inhaler and SeretideTM 250 EvohalerTM in healthy volunteers with charcoal block.

AsthmaChronic Obstructive Pulmonary Disease (COPD)

Intech Biopharm Ltd.45 participantsStarted Aug 2014

New Taipei City, Taiwan

Study Evaluating Preference, Satisfaction and Ease of Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD) Diagnosed Patients

Long-term Oxygen Treatment (LTOT) in Chronic Obstructive Pulmonary Disease: Factors Influencing Survival

Bioequivalence Study of Synflutide HFA Inhaler and Seretide Evohaler in Healthy Volunteers With Charcoal Block

Related Searches

In Vitro Assessment of a Breath-synchronized Vibrating Mesh Nebulizer During Non Invasive Ventilation

Assessment of the Effects of an Intermediate Care Package in Preventing Hospitalisation of Patients With COPD

Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)

Is COPD a Risk Factor for Cardiovascular Disease?

Preference, Satisfaction and Ease of Use of Genuair® (Pressair™) and Breezhaler® (Neohaler™) Inhalers in Patients With COPD

Urgent Medical and Surgical Conditions During Flights

A Pilot Study to Evaluate a Telepharmacy Intervention to Improve Inhaler Adherence in Veterans With COPD

Macrophages in Smokers' Lung

Effects of IPV Assessed With Functional Imaging

A Prospective, Observational Study of COPD Patients in U.S. Hospitals

Falling in Patients With COPD Referred to Pulmonary Rehabilitation: Incidence, Risk Factors and Prediction Tools

Comparison of Indacaterol 150 mcg Once Daily (o.d.) With Salmeterol/Fluticasone Propionate 50 mcg/500 mcg Twice Daily (b.i.d.)

Lung Disease Collection (Qatar): Evaluation of the Lungs of Individuals With Lung Disease

Effects Of Oral Prednisolone On Bone Metabolism In Patients With Chronic Obstructive Pulmonary Disease

Advanced Immunological Approach in COPD Exacerbation

Does Moderate Intensity Exercise Help Prevent Smoking Relapse Among Women?

Prevalence and Predictors of Depression in COPD